# A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study

> **NCT06325293** · NA · RECRUITING · sponsor: **Christoph Berger** · enrollment: 376 (estimated)

## Conditions studied

- Community Acquired Pneumonia in Children
- Mycoplasma Pneumoniae
- Mycoplasma Pneumoniae Pneumonia

## Interventions

- **DRUG:** Azithromycin Pfizer®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06325293
- **Lead sponsor:** Christoph Berger
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 376 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325293, "A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06325293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*